Suppr超能文献

嵌合青病毒素-MPER 重组工程蛋白导致 HIV-1 的无细胞病毒溶解。

Chimeric Cyanovirin-MPER recombinantly engineered proteins cause cell-free virolysis of HIV-1.

机构信息

Drexel University College of Medicine, Department of Biochemistry and Molecular Biology, Philadelphia, Pennsylvania, USA.

出版信息

Antimicrob Agents Chemother. 2013 Oct;57(10):4743-50. doi: 10.1128/AAC.00309-13. Epub 2013 Jul 15.

Abstract

Human immunodeficiency virus (HIV) is the primary etiologic agent responsible for the AIDS pandemic. In this work, we used a chimeric recombinant protein strategy to test the possibility of irreversibly destroying the HIV-1 virion using an agent that simultaneously binds the Env protein and viral membrane. We constructed a fusion of the lectin cyanovirin-N (CVN) and the gp41 membrane-proximal external region (MPER) peptide with a variable-length (Gly4Ser)x linker (where x is 4 or 8) between the C terminus of the former and N terminus of the latter. The His-tagged recombinant proteins, expressed in BL21(DE3)pLysS cells and purified by immobilized metal affinity chromatography followed by gel filtration, were found to display a nanomolar efficacy in blocking BaL-pseudotyped HIV-1 infection of HOS.T4.R5 cells. This antiviral activity was HIV-1 specific, since it did not inhibit cell infection by vesicular stomatitis virus (VSV) or amphotropic-murine leukemia virus. Importantly, the chimeric proteins were found to release intraviral p24 protein from both BaL-pseudotyped HIV-1 and fully infectious BaL HIV-1 in a dose-dependent manner in the absence of host cells. The addition of either MPER or CVN was found to outcompete this virolytic effect, indicating that both components of the chimera are required for virolysis. The finding that engaging the Env protein spike and membrane using a chimeric ligand can destabilize the virus and lead to inactivation opens up a means to investigate virus particle metastability and to evaluate this approach for inactivation at the earliest stages of exposure to virus and before host cell encounter.

摘要

人类免疫缺陷病毒(HIV)是导致艾滋病大流行的主要病原体。在这项工作中,我们使用嵌合重组蛋白策略来测试使用同时结合 Env 蛋白和病毒膜的试剂来不可逆地破坏 HIV-1 病毒粒子的可能性。我们构建了一个融合物,其中包含凝集素 cyanovirin-N(CVN)和 gp41 膜近端外部区域(MPER)肽,在前者的 C 末端和后者的 N 末端之间通过一个(Gly4Ser)x 接头(其中 x 是 4 或 8)连接。表达在 BL21(DE3)pLysS 细胞中的 His 标记的重组蛋白,通过固定化金属亲和层析和凝胶过滤进行纯化,发现能够以纳摩尔效力阻断 BaL 假型 HIV-1 感染 HOS.T4.R5 细胞。这种抗病毒活性是 HIV-1 特异性的,因为它不会抑制水疱性口炎病毒(VSV)或嗜性鼠白血病病毒感染细胞。重要的是,发现嵌合蛋白在不存在宿主细胞的情况下,以剂量依赖性方式从 BaL 假型 HIV-1 和完全感染性 BaL HIV-1 中释放出病毒内 p24 蛋白。添加 MPER 或 CVN 均可竞争这种病毒裂解作用,表明嵌合体的两个成分都需要病毒裂解。发现使用嵌合配体结合 Env 蛋白刺突和膜可以使病毒不稳定并导致失活,这为研究病毒粒子的亚稳定性以及评估这种方法在接触病毒和宿主细胞之前的最早阶段进行失活提供了一种手段。

相似文献

引用本文的文献

本文引用的文献

1
HIV: cell binding and entry.HIV:细胞结合与进入。
Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a006866. doi: 10.1101/cshperspect.a006866.
2
Microbicides: still a long road to success.杀微生物剂:通往成功之路仍漫长。
Trends Microbiol. 2012 Aug;20(8):369-75. doi: 10.1016/j.tim.2012.05.005. Epub 2012 Jun 15.
3
Designed oligomers of cyanovirin-N show enhanced HIV neutralization.设计的氰病毒 N 寡聚物显示出增强的 HIV 中和作用。
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14079-84. doi: 10.1073/pnas.1108777108. Epub 2011 Jul 28.
5
Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.通过结合 gp120 和 gp41 来抑制 HIV-1 的有效策略。
Antimicrob Agents Chemother. 2011 Jan;55(1):264-75. doi: 10.1128/AAC.00376-10. Epub 2010 Oct 18.
8
The antiviral protein cyanovirin-N: the current state of its production and applications.抗病毒蛋白氰病毒-N:其生产和应用的现状。
Appl Microbiol Biotechnol. 2010 Apr;86(3):805-12. doi: 10.1007/s00253-010-2470-1. Epub 2010 Feb 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验